Project Number V1701 Agency/Funding Organization Fondation Vaincre Alzheimer (France) Funding Year 2017 View Full Project Details for Oral administration of MSX-3, an adenosine A2AR antagonist, reduces amyloid load and memory deficits of APP/PS1dE9 mice Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category F. Research Resources 3. Professional and Career Development c. Career Development Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) d. Neurotransmitter Receptors Researcher and Organization Principal Investigator Emilie Faivre Principal Investigator First Name Emilie Principal Investigator Last Name Faivre Awardee Organization Jean-Pierre Aubert Research Center Contact PI Country France Project Detail FY Overall Cost $750 Funding Organization Agency/Funding Organization Fondation Vaincre Alzheimer (France) Funding Organization Country France
